Cancer screening is the only circumstance in which apparently healthy people subject themselves purposely to an agent known to cause cancer. It is the paradox of mammography, a screening tool that has substantially reduced breast cancer morbidity, whose success has only added to its paradoxical nature.

MIM Software Inc. announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance to market full MIM products running on tablets through thin client technology such as Citrix.

Researchers using contrast-enhanced magnetic resonance imaging (MRI) have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer’s disease (AD), according to a new study published online in the journal Radiology.

The governors of Tennessee and New Hampshire have signed into law measures that establish licensure standards for radiologic technologists in their states.

CorTechs Labs and Olea Medical announced a partnership agreement to offer NeuroQuant in Olea Sphere, Olea Medical’s suite of imaging applications.

Medic Vision Imaging Solutions Ltd. announced the U.S. Food and Drug Administration (FDA) clearance of SafeCT-29 to help healthcare facilities achieve compliance as mandated by NEMA XR-29 “Smart Dose” standard.

The American College of Radiology (ACR) released eight new and 15 updated Appropriateness Criteria, which define national guidelines for the most appropriate medical imaging exam or radiation therapy.

Vermont Gov. Peter Shumlin signed the Dense Breast Tissue Reporting Senate Bill 157 into law this week, adding to the growing list of density reporting laws across the country.

May 26, 2016 — Radiation oncologists from across the United States convened on Capitol Hill this week to encourage members of Congress to invest in cancer research with sustainable and predictable funding. Their other goal was to protect patients’ access to high-quality cancer care through value-based physician payment models.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now